Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
01.10.25
/
50%
€115.08
Target price
01.10.26
€133.73
Performance (%)
-10.18%
Price
21.01.26
€103.36
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -10.18%. This prediction currently runs until 01.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.744% | -3.744% |
| iShares Core DAX® | -1.933% | 2.239% |
| iShares Nasdaq 100 | -0.972% | 0.226% |
| iShares Nikkei 225® | -2.056% | 5.685% |
| iShares S&P 500 | -1.185% | 0.867% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $153.00 to $157.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.22
15.01.26
15.01.26
€130.60
15.01.27
15.01.27
-2.88%
21.01.26
21.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-22.53%
21.01.26
21.01.26